Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations.

Gordon, Jaymeson; Bravo-Perez, Carlos; Guarnera, Luca; Unlu, Serhan; Kawashima, Naomi; Ahmed, Arooj; Haddad, Christopher; Kubota, Yasuo; Nautiyal, Ishani; Ullah, Fauzia; Dima, Danai; Williams, Nakisha D; Kewan, Tariq; Bahaj, Waled; Carraway, Hetty E; Yang, Chao-Yie; Gurnari, Carmelo; Visconte, Valeria; Maciejewski, Jaroslaw P

Gordon, Jaymeson; Bravo-Perez, Carlos; Guarnera, Luca; Unlu, Serhan; Kawashima, Naomi; Ahmed, Arooj; Haddad, Christopher; Kubota, Yasuo; Nautiyal, Ishani; Ullah, Fauzia; Dima, Danai; Williams, Nakisha D; Kewan, Tariq; Bahaj, Waled; Carraway, Hetty E; Yang, Chao-Yie; Gurnari, Carmelo; Visconte, Valeria; Maciejewski, Jaroslaw P.

Affiliation

Gordon J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Bravo-Perez C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Guarnera L; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain.
Unlu S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Kawashima N; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Ahmed A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Haddad C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Kubota Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Nautiyal I; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Ullah F; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Dima D; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Williams ND; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Kewan T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Bahaj W; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Carraway HE; Department of Hematology and Medical Oncology, Yale University, New Haven, CT, USA.
Yang CY; Division of Medical Oncology & Hematology, School of Medicine University of Louisville, Louisville, KY, USA.
Gurnari C; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Visconte V; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Blood Cancer J ; 14(1): 125, 2024 Jul 30.

Article de En | MEDLINE | ID: mdl-39080258

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mutation germinale / Tyrosine kinase-3 de type fms Limites: Female / Humans / Male Langue: En Journal: Blood Cancer J / Blood cancer journal Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google